CA Patent

CA2837400C — 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors

Assigned to Mycovia Pharmaceuticals Inc · Expires 2017-12-12 · 8y expired

What this patent protects

The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes. The invention describes a compound of Formula (I), or salt thereof, wherein: (see formula I) MBG is…

USPTO Abstract

The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes. The invention describes a compound of Formula (I), or salt thereof, wherein: (see formula I) MBG is optionally substituted tetrazolyl, optionally substituted triazolyl, or optionally. substituted pyrazolyl; R1 is halo; R2 is halo; each R3 is independently alkyl, cyano, haloalkyl, alkoxy, halo, haloalkoxy, R4 is aryl optionally substituted with 0, 1, 2 or 3 independent R3; R5 is H, or -C(O)alkyl optionally substituted with amino; n is 0, 1, 2 or 3.

Drugs covered by this patent

Patent Metadata

Patent number
CA2837400C
Jurisdiction
CA
Classification
—
Expires
2017-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Mycovia Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.